Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | CRSP | LEGN | ||
| Company | Akero Therapeutics Inc | Crispr Therapeutics Ag | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.52 | 47.92 | 22.80 | ||
| High | 54.83 | 48.07 | 23.15 | ||
| Low | 54.37 | 45.90 | 22.18 | ||
| Latest | 54.65 | 46.54 | 22.22 | ||
| Change | +0.10 | -0.99 | -1.31 | ||
| % Change | +0.18% | -2.08% | -5.57% | ||
| Volume | 15,312,200 | 1,389,500 | 1,693,900 | ||
| 20-Day Average Volume | 2,420,955 | 1,802,735 | 1,925,040 | ||
| Previous Close | 54.55 | 47.53 | 23.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.38 | 52.92 | 26.01 | ||
| 20-Day Raw Stochastic | 78.26% | 3.65% | 2.07% | ||
| 20-Day Relative Strength | 65.57 | 39.79 | 36.51 | ||
| Weighted Alpha | +16.80 | -29.41 | -42.22 | ||
| Today's Opinion | 100% Buy | 56% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 16% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 12/01/25 | -2.60% since 07/17/26 | -0.18% since 07/17/26 | ||
| Low | 54.29 on 12/05/25 | 45.90 on 07/24/26 | 22.05 on 07/20/26 | ||
| High | 54.83 on 12/08/25 | 48.62 on 07/21/26 | 24.05 on 07/23/26 | ||
| 1-Month | |||||
| %Chg | +1.13% since 11/07/25 | -13.09% since 06/24/26 | -24.37% since 06/24/26 | ||
| Low | 54.02 on 11/10/25 | 45.90 on 07/24/26 | 22.05 on 07/20/26 | ||
| High | 54.83 on 12/08/25 | 63.45 on 07/06/26 | 30.27 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +22.62% since 09/08/25 | -4.60% since 04/24/26 | -7.03% since 04/24/26 | ||
| Low | 41.77 on 09/15/25 | 45.90 on 07/24/26 | 22.05 on 07/20/26 | ||
| High | 54.83 on 12/08/25 | 63.45 on 07/06/26 | 37.50 on 06/03/26 | ||
| 6-Month | |||||
| %Chg | +0.68% since 06/06/25 | -16.17% since 01/23/26 | +16.89% since 01/23/26 | ||
| Low | 41.77 on 09/15/25 | 44.12 on 03/30/26 | 16.24 on 02/04/26 | ||
| High | 57.35 on 06/27/25 | 63.45 on 07/06/26 | 37.50 on 06/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,499,006 | 4,584,221 | 4,370,463 | ||
| Shares Outstanding, K | 82,324 | 96,449 | 185,740 | ||
| Annual Sales | 0 | 3,510,000 | 1,028,900,000 | ||
| Annual Net Income | -252,060,000 | -581,600,000 | -296,800,000 | ||
| Last Quarter Sales | 0 | 1,460,000 | 305,100,000 | ||
| Last Quarter Net Income | -81,570,000 | -122,930,000 | -54,300,000 | ||
| 60-Month Beta | -0.40 | 1.71 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/07/25 | -1.28 on 05/04/26 | -0.15 on 05/12/26 | ||
| Earnings Date | 02/27/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||